
Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors
Absztrakt Immune-checkpoint inhibitors show promising effects in the treatment of multiple tumor types. Biomarkers are biological indicators used to select patients for a systemic anticancer treatment, but there are only a few clinically useful biomarkers such as PD-L1 expression and…
